Cargando…

Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?

Non-alcoholic fatty liver disease represents the most common chronic liver disease in obese children of industrialized countries. Nowadays the first line of treatment of pediatric non-alcoholic fatty liver disease is based on dietary and lifestyle intervention; however compliance to these interventi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verduci, Elvira, Lassandro, Carlotta, Radaelli, Giovanni, Soldati, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391476/ https://www.ncbi.nlm.nih.gov/pubmed/25889212 http://dx.doi.org/10.1186/s12967-015-0471-7

Ejemplares similares

Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?
por: Lassandro, Carlotta, et al.
Publicado: (2015)

Change in Metabolic Profile after 1-Year Nutritional-Behavioral Intervention in Obese Children
por: Verduci, Elvira, et al.
Publicado: (2015)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

Pediatric obesity is associated with an altered gut microbiota and discordant shifts in F irmicutes populations
por: Riva, Alessandra, et al.
Publicado: (2016)

Protein intake and nutritional programming: metabolic consequences
por: Verduci, Elvira, et al.
Publicado: (2014)

Circulating Salicylic Acid and Metabolic Profile after 1-Year Nutritional–Behavioral Intervention in Children with Obesity
por: Vizzari, Giulia, et al.
Publicado: (2019)

Effect of individual- versus collective-based nutritional-lifestyle intervention on the atherogenic index of plasma in children with obesity: a randomized trial
por: Verduci, Elvira, et al.
Publicado: (2021)

Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity
por: Calcaterra, Valeria, et al.
Publicado: (2022)

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
por: Nobili, Valerio, et al.
Publicado: (2014)

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

School Nutrition Program; Prevention of Obesity and Fatty Liver in Children
por: Ardalan, Gelayol, et al.
Publicado: (2014)

Enhanced Amelioration of High-Fat Diet-Induced Fatty Liver by Docosahexaenoic Acid and Lysine Supplementations
por: Lin, Hsin-Yu, et al.
Publicado: (2014)

Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice
por: Soni, Nikul K, et al.
Publicado: (2015)

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
por: Kasper, Philipp, et al.
Publicado: (2023)

Blood Fatty Acids Profile in MIS-C Children
por: Verduci, Elvira, et al.
Publicado: (2021)

Thyroid Function in Obese Children with Non-Alcoholic Fatty Liver Disease
por: Bilgin, Hüseyin, et al.
Publicado: (2014)

Effects of a High-Fat Diet and Docosahexaenoic Acid during Pregnancy on Fatty Acid Composition in the Fetal Livers of Mice
por: Álvarez, Daniela, et al.
Publicado: (2023)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
por: Borja-Magno, Angélica, et al.
Publicado: (2023)

Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review
por: Banderali, G., et al.
Publicado: (2015)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Optimal diagnosis and management of non-alcoholic fatty liver disease
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Genetic Polymorphisms in Non-alcoholic Fatty Liver Disease in Obese Egyptian Children
por: El-Koofy, Nehal M., et al.
Publicado: (2011)

Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity
por: Jimenez-Rivera, Carolina, et al.
Publicado: (2017)

The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity
por: Hazer, İlhan, et al.
Publicado: (2020)

A Nomogram for Predicting Non-Alcoholic Fatty Liver Disease in Obese Children
por: Kim, Ahlee, et al.
Publicado: (2020)

Docosahexaenoic Acid Esters of Hydroxy Fatty Acid Is a Novel Activator of NRF2
por: B. Gowda, Siddabasave Gowda, et al.
Publicado: (2021)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
por: Shim, Ju Hyun
Publicado: (2020)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles
por: Murru, Elisabetta, et al.
Publicado: (2022)

The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings
por: de Silva, Mawanane Hewa Aruna Devapriya, et al.
Publicado: (2022)

Thyroid Hormone Levels in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease
por: Torun, Emel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1crtibdu04orah6329eeg3fsgh